Regeneron Pharmaceuticals (NQ: REGN )
1,060.86
+5.29
(+0.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 24, 2024
Add to My Watchlist
Headline News about Regeneron Pharmaceuticals![]() ![]() ![]()
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]()
CytomX Shares Jump After Cancer Therapy Pact With Pharma Major Regeneron
November 17, 2022
Via Benzinga
Regeneron Pharmaceuticals's Return On Capital Employed Overview
November 17, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|